
USANA Health Sciences, Inc. (USNA) Q2 2026 Earnings Call Transcript
Seeking Alpha
Published: Aug 05, 2026, 07:20 PM
SA Transcripts 161.52K Followers Follow USANA Health Sciences, Inc. ( USNA ) Q2 2026 Earnings Call August 5, 2026 11:00 AM EDT Company Participants Andrew Masuda - Director of Investor Relations Kevin Guest - CEO & Executive Chairman Doug Hekking Brent Neidig Walter Noot Dave Bagley Conference Call Participants Anthony Lebiedzinski Ivan Feinseth Presentation Operator If anyone should require operator assistance during the conference, please press star 0 on your telephone keypad. As a reminder, this conference is being recorded. I'd now like to turn the conference over to your host, Andrew Masuda, Director of Investor Relations. Please go ahead. Andrew Masuda Director of Investor Relations Thank you, and good morning, everyone. We appreciate you joining us to review our second quarter results. Today's conference call is being broadcast live via webcast and can be accessed directly from our website at ir.usana.com. Shortly following the call, a replay will be available on our website. As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events or the future financial performance of our company. Those statements involve risks and uncertainties that could cause actual results to differ, perhaps materially, from the results projected in such forward-looking statements. Examples of these statements include those regarding our strategies and outlook for fiscal 2026, uncertainty related to the economic and operating environment around the world, and our operations and financial results. We caution you that these statements should be considered in conjunction with disclosures, including specific risk factors and financial data contained in our most recent filings with the SEC. I'm joined by our Chairman and Chief Executive Officer, Kevin Guest, our Chief Financial Officer, Doug Hekking, our Chief Commercial Officer, Brent Neidig, our Chief Operating Officer, Walter Noot, our Chief Scientific Officer, [ Dr. Catherine Armstrong ], as well as other executives. Yesterday, after the market closed, we announced our second quarter results and posted our management commentary document on the company's website. We'll
Source: Seeking Alpha
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.